Search Results

You searched for : AbbVie  

Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’

The screenings served as a valuable resource, ensuring that timely interventions could be made for those in need of further diagnosis and treatment, reinforcing the ...
Nov 16

Bhopal Hosts Third State-Level Consultation on Glaucoma Prevention

A panel discussion followed which brought together specialists who discussed various approaches to managing glaucoma, followed by an interactive Q&A session where attendees had ...
Sep 23

Sightsavers India and AbbVie India Hosted a State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’ in Lucknow

The consultation also featured a free glaucoma screening session for attendees aged 40 and above, led by Dr Suneeta Dubey and her team, ensuring participants ...
Aug 26

Sightsavers India and AbbVie India Host Successful State-Level Consultation on Glaucoma Awareness

A highlight of the event was the glaucoma screening offered to attendees aged 40 and above, ensuring that participants had access to immediate and practical ...
Jun 29

AbbVie India and Sightsavers India Collaborate to Raise Awareness on Glaucoma

...
May 02

AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research

Latest pharma news updates...
Nov 12

AbbVie, Eisai, and EA Pharma launch “Humira support tool ordering service for Patients”

Latest pharma news update...
Sep 16

Mission and AbbVie collaboration in Alzheimer’s and Parkinson’s diseases reaches next milestone

Latest Pharma News Update...
Aug 10

AbbVie and Calico announce Second Extension of collaboration focused on aging and age-related Diseases

Latest Pharma Update...
Jul 30

Top pharma stocks for long term investing : The companies to watch for in next 5 years

The pharma stocks for long term wealth creation ...
Jan 11

Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials

Harbour BioMed, and Utrecht University today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the ...
Dec 15

I-Mab accelerates clinical development of anti-CD47 monoclonal antibody lemzoparlimab in the US and China

I-Mab's global collaboration with AbbVie will facilitate global development of lemzoparlimab...
Dec 05

AbbVie and Frontier Medicines establish global partnership for research and development

The partnership will address novel therapies and E3 Degraders against difficult-to-drug targets...
Dec 04

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Testosterone Gel

Testosterone Gel, is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone....
Nov 25

Alembic Pharmaceuticals announces USFDA Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg.

Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg have an estimated market size of US$ 17 million for twelve months ending June 2020 ...
Oct 21

AbbVie submits regulatory applications to US FDA and EMA for RINVOQ (upadacitinib) in atopic dermatitis

These submissions are an important step forward in the commitment to providing an additional treatment option ...
Oct 20

AbbVie received US FDA approval for the treatment of acute myeloid leukemia

...
Oct 17

Eli Lilly announces agreement to acquire Disarm Therapeutics

Eli Lilly successfully develop and commercialize new medicines resulting from the acquisition...
Oct 16

NIH study aims to identify promising COVID-19 treatments for larger clinical trials

Approximately 100 hospitalized volunteers will be assigned to each study arm with each of the study sites testing no more than three investigational treatments at ...
Oct 14

Lupin Launches Divalproex Sodium ER Tablets USP

Pharma major Lupin Limited announced the launch of Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500 mg, after an approval by U....
Sep 22

ACTO acquires Scrimmage, disrupting Life Sciences learning and engagement market

ACTO cements its position as the largest life sciences commercial learning and development platform ...
Sep 15

AbbVie and I-Mab have collaborated for the treatment of multiple cancers

AbbVie and I-Mab enter Into global strategic partnership for differentiated immuno-oncology therapy ...
Sep 04

Positive phase 3 data for atogepant in migraine prevention

AbbVie announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant in migraine prevention...
Jul 31

AbbVie submits regulatory applications to FDA and EMA for RINVOQ

RINVOQ will be used for the treatment of adults with Active Psoriatic Arthritis...
Jun 08

BioMed X Institute launches Rapid Antiviral Response Platform for pandemics

BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany. ...
May 18

25 Matching result(s) found!

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024